ConductScience.org, home

Paper3733147

The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.

Kitamura H and 2 others. Immunology, 1986. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system. Papers, record 3733147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3733147

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
PubMed
Journal
Immunology
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kitamura HH
2Tsuboi MM
3Nagaki KK

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement ActivationMajor topic
Complement C3Major topic
Complement C5Major topic
Complement Pathway, ClassicalMajor topic
Animals
Antibodies
Complement System Proteins
Dose-Response Relationship, Immunologic
Erythrocytes
Guinea Pigs
Hemolysis
Humans
Magnesium

Source PubMed

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,960,883Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.Immunochemistry1966https://conductscience.org/library/papers/5960883PubMed
295,812Deficiency of the ninth component of complement in man.J Clin Lab Immunol1979https://conductscience.org/library/papers/95812PubMed
34,179,470The relationship of the hemolytic activity of active C'1s to its TAMe esterase action: a new method of purification and assay.J Immunol1969https://conductscience.org/library/papers/4179470PubMed
44,182,367The ninth component of human complement: isolation, description and mode of action.Immunology1969https://conductscience.org/library/papers/4182367PubMed
54,193,935Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.J Exp Med1970https://conductscience.org/library/papers/4193935PubMed
65,470,509Lysis of erythrocytes by complement in the absence of antibody.J Exp Med1970https://conductscience.org/library/papers/5470509PubMed
74,748,119The complement system.Sci Am1973https://conductscience.org/library/papers/4748119PubMed
84,213,402Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.J Immunol1974https://conductscience.org/library/papers/4213402PubMed
94,214,868Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8.J Immunol1974https://conductscience.org/library/papers/4214868PubMed
101,249,415Purification of the sixth and seventh component of human complement without loss of hemolytic activity.J Immunol1976https://conductscience.org/library/papers/1249415PubMed
111,218,074
Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
Biken J1975https://conductscience.org/library/papers/1218074PubMed
12950,465C3 requirements for formation of alternative pathway C5 convertase.J Immunol1976https://conductscience.org/library/papers/950465PubMed
13823,964Third component of human complement: purification from plasma and physicochemical characterization.Biochemistry1976https://conductscience.org/library/papers/823964PubMed
14322,709Purification and structural analysis of the fourth component of human complement.Biochemistry1977https://conductscience.org/library/papers/322709PubMed
15659,890The complex of C5b and C6: isolation, characterization, and identification of a modified form of C5b consisting of three polypeptide chains.J Immunol1978https://conductscience.org/library/papers/659890PubMed
16106,884Fifth component of human complement: purification from plasma and polypeptide chain structure.Biochemistry1979https://conductscience.org/library/papers/106884PubMed
177,350,230The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.J Immunol1980https://conductscience.org/library/papers/7350230PubMed
186,986,046Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.Prog Allergy1980https://conductscience.org/library/papers/6986046PubMed
196,911,149
Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
J Immunol1981https://conductscience.org/library/papers/6911149PubMed
207,265,179Further studies on C9 deficiency.J Clin Lab Immunol1981https://conductscience.org/library/papers/7265179PubMed

See all 26 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
41,800,440A second generation of C3 humanized rats for preclinical evaluation of human C3 inhibitors.Blood Vessel Thromb Hemost2026https://conductscience.org/library/papers/41800440PubMed
40,535,418Effects of Small Extracellular Vesicles Derived From Mesenchymal Stromal Cells on Acute Kidney Injury: A Rat Ischemia-Reperfusion Model.Cureus2025https://conductscience.org/library/papers/40535418PubMed
31,196,848Absence of complement component 3 does not prevent classical pathway-mediated hemolysis.Blood Adv2019https://conductscience.org/library/papers/31196848PubMed
3,759,127C3-independent immune haemolysis: mechanism of membrane attack complex formation.Immunology1986https://conductscience.org/library/papers/3759127PubMed

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
C5727PubTator's text mininghttps://conductscience.org/library/genes/727NCBI Gene
C5AR1728PubTator's text mininghttps://conductscience.org/library/genes/728NCBI Gene
CDK5RAP151,654PubTator's text mininghttps://conductscience.org/library/genes/51654NCBI Gene
CRLS154,675PubTator's text mininghttps://conductscience.org/library/genes/54675NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3733147

GET https://conductscience.org/api/papers/v1/3733147/references?page=2